Literature DB >> 3437298

Late onset parkinsonian syndrome in Hallervorden-Spatz disease.

R Alberca1, E Rafel, I Chinchon, J Vadillo, A Navarro.   

Abstract

Two siblings, from consanguineous parents, developed in their twenties a Parkinsonian syndrome. In the elder, the disease evolved for 13 years and the necropsic study was diagnostic of Hallervorden-Spatz disease. The younger sibling is severely affected after 12 years of the disorder. Several CT and one MR studies done in this patient during the last 4 years have been normal. Ultrastructural studies of the bone marrow histiocytes and blood lymphocytes disclosed peculiar inclusions. Bromocriptine in low doses proved to be a beneficial therapy for this patient.

Entities:  

Mesh:

Year:  1987        PMID: 3437298      PMCID: PMC1032609          DOI: 10.1136/jnnp.50.12.1665

Source DB:  PubMed          Journal:  J Neurol Neurosurg Psychiatry        ISSN: 0022-3050            Impact factor:   10.154


  7 in total

1.  Hallervorden-Spatz syndrome.

Authors:  E C Dooling; W C Schoene; E P Richardson
Journal:  Arch Neurol       Date:  1974-01

2.  MR imaging of Hallervorden-Spatz disease.

Authors:  P J Littrup; S S Gebarski
Journal:  J Comput Assist Tomogr       Date:  1985 May-Jun       Impact factor: 1.826

3.  Sea-blue histiocytes, lymphocytic cytosomes, movement disorder and 59Fe-uptake in basal ganglia: Hallervorden-Spatz disease or ceroid storage disease with abnormal isotope scan?

Authors:  K F Swaiman; S A Smith; G L Trock; A R Siddiqui
Journal:  Neurology       Date:  1983-03       Impact factor: 9.910

4.  Computed tomography in Hallervorden-Spatz disease.

Authors:  E C Dooling; E P Richardson; K R Davis
Journal:  Neurology       Date:  1980-10       Impact factor: 9.910

5.  Thyroid function in Parkinson disease.

Authors:  J R Berger; R E Kelley
Journal:  Neurology       Date:  1981-01       Impact factor: 9.910

6.  Late-onset Hallervorden-Spatz disease presenting as familial parkinsonism.

Authors:  J Jankovic; J B Kirkpatrick; K A Blomquist; P J Langlais; E D Bird
Journal:  Neurology       Date:  1985-02       Impact factor: 9.910

7.  Hallervorden-Spatz disease: cysteine accumulation and cysteine dioxygenase deficiency in the globus pallidus.

Authors:  T L Perry; M G Norman; V W Yong; S Whiting; J U Crichton; S Hansen; S J Kish
Journal:  Ann Neurol       Date:  1985-10       Impact factor: 10.422

  7 in total
  5 in total

1.  Atypical dopa responsive parkinsonism in a patient with megalencephaly, midbrain Lewy body disease, and some pathological features of Hallervorden-Spatz disease.

Authors:  P J Tuite; J P Provias; A E Lang
Journal:  J Neurol Neurosurg Psychiatry       Date:  1996-11       Impact factor: 10.154

Review 2.  Nigral iron elevation is an invariable feature of Parkinson's disease and is a sufficient cause of neurodegeneration.

Authors:  Scott Ayton; Peng Lei
Journal:  Biomed Res Int       Date:  2014-01-16       Impact factor: 3.411

3.  Hallervorden-Spatz disease.

Authors:  Maseumeh Dashti; Ahmad Chitsaz
Journal:  Adv Biomed Res       Date:  2014-09-12

4.  Iron accumulation confers neurotoxicity to a vulnerable population of nigral neurons: implications for Parkinson's disease.

Authors:  Scott Ayton; Peng Lei; Paul A Adlard; Irene Volitakis; Robert A Cherny; Ashley I Bush; David I Finkelstein
Journal:  Mol Neurodegener       Date:  2014-07-10       Impact factor: 14.195

Review 5.  Parkinson's Disease and Metal Storage Disorders: A Systematic Review.

Authors:  Edward Botsford; Jayan George; Ellen E Buckley
Journal:  Brain Sci       Date:  2018-10-31
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.